The issue that should be first and foremost with any self respecting shareholder is what is happening with our 3 in house Dep drug commercialisation discussions and are we going to see any worthwhile deals struck. This has been the focus of this company for 20 years. Yes 20 years.
This new partnership at best will take a minimum of 10 years before anything meaningful transpires. Suggesting 3 to 4 years for POC is a total nonsense and those that believe that are totally delusional. It's not even at the pre clinical stage yet. This type of statement should ring alarm bells.
For us shareholders the main event will be the forthcoming May webinar where we will have the opportunity to ask the curly questions.
And a word of warning for this event. Do NOT send your questions in to investor relations prior to the event as they request. In the past from my personal experience they edit them and reconstruct the questions to avoid having to deal with issues they would rather not discuss. Wait until the day and ask them in real time over the phone or attend in person if they are conducting that type of meeting.
SPL Price at posting:
14.0¢ Sentiment: None Disclosure: Held
